BIOMETRIJA, UAB - financials and debts

Company age: 31 y. 2 mo.

Update

BIOMETRIJA - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 639,034 736,592 719,679 824,116 881,283 887,985 789,956 996,216
Profit before tax 63,395 74,671 118,555 132,917 114,746 105,040 78,366 155,076
Net profit 53,810 63,258 100,928 113,001 98,079 89,593 66,831 131,060
Equity 308,690 291,949 336,647 369,649 354,728 354,320 331,646 402,710
Liabilities 0 143,968 99,388 189,676 114,618 28,069 9,627 35,755
Non-current assets 24,042 17,078 12,631 52,948 44,690 35,519 22,449 45,160
Current assets 377,616 418,839 423,404 506,377 424,656 413,102 384,859 493,852
Total assets 401,658 435,917 436,035 559,325 469,346 448,621 407,308 539,012
Taxes paid
STI taxes - - - - - 176,467 160,333 174,268
Social insurance contributions - - - - - 14,804 15,278 17,758
Financial indicators
Revenue change y/y -25.4% +15.3% -2.3% +14.5% +6.9% +0.8% -11.0% +26.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 13.4% 14.5% 23.1% 20.2% 20.9% 20.0% 16.4% 24.3%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 17.4% 21.7% 30.0% 30.6% 27.6% 25.3% 20.2% 32.5%
Profit margin Net profit margin. Shows the overall profitability of the company. 8.4% 8.6% 14.0% 13.7% 11.1% 10.1% 8.5% 13.2%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 9.9% 10.1% 16.5% 16.1% 13.0% 11.8% 9.9% 15.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 0.5 0.3 0.5 0.3 0.1 0.0 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 127,807 147,318 143,936 164,823 176,257 177,597 157,991 166,036

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

BIOMETRIJA - Social security debts

From To Debt, €
2021-11-16 2021-12-14 0.32
2021-11-05 2021-11-14 0.32
2021-09-16 2021-09-26 7.69

BIOMETRIJA - VMI tax arrears

From To Overdue, €
2026-05-19 2026-05-20 7.18
2026-05-13 2026-05-14 12307.43
2026-05-12 2026-05-12 12307.32
2026-05-07 2026-05-11 11602.96
2025-03-20 2025-03-24 0.08
2025-02-28 2025-03-12 1.18
2025-02-20 2025-02-25 0.05

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
BIOMETRIJA, UAB (code 123221635) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In financial year 2025, the company generated revenue of €996.2K and net profit of €131.1K, up from €790.0K revenue and €66.8K net profit in 2024 and €888.0K revenue and €89.6K net profit in 2023. The 2025 profit margin improved to 13.2%, compared with 8.5% in 2024 and 10.1% in 2023, indicating stronger profitability after a softer 2024. The latest year also shows solid growth momentum, with revenue increasing by 26.1% year on year and by 12.2% over two years. As of 2025, total assets stood at €539.0K, equity at €402.7K and liabilities at €35.8K, leaving a strong equity ratio of 74.7% and a debt-to-equity ratio of 0.09. Asset turnover reached 1.85x. With revenue per employee of €166.0K and profit per employee of €21.8K, the company showed efficient operations in 2025.